GlaxoSmithKline: Making an impact on emerging markets

Authored by Abbas Hussain, Senior Partner, C-Bridge Capital

Criticaleye recently caught up with Abbas Hussain, President, Emerging Markets at GlaxoSmithKline, to discuss the state of  emerging markets and the initial stages of GSK’s low-cost drug plan, a revolutionary scheme set to change the face of the pharmaceutical industry.

Share this with your Community





Click here to download this insight

DOWNLOAD INSIGHT



Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.


Inspiring Leaders Podcast: Cyber Resilience — How Secure Are You, Really? (ft. Jon Rigby)

Jon Rigby CBE, Senior Cyber Advisor and former Chief Cyber Officer at Liberty Specialty Markets, joins Jacob Ambrose Willson, Senior Editor at Criticaleye, to explore what it truly takes for organisations to build cy...


Click here to download this insight

VIEWPOINTS | International Expansion in a Nutshell

Once a business has reached maturity in its home market, attention naturally turns to international expansion as the next growth frontier.   Nick Burns has first-hand experience of this during his time as ...


Inspiring Leaders Podcast: Claire Ainscough, CPO at Ocado on Leading People and Culture

Claire Ainscough, Chief People Officer (CPO) at Ocado Group joins Bridgette Hall to explore what it takes to lead the people agenda in a fast-moving, technology-driven business. As ...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 194




London Stock Exchange Group Southern Water Mayborn Group NATS Rolls-Royce E.ON UK Hitachi Solutions AlixPartners CrowdStrike Legal & General LACE Partners British Land Aldermore Group Worldpay Lightsource bp GlaxoSmithKline plc Drax Group plc NatWest Group Canaccord Genuity Group Inc Stream